Expansion Opportunities Novogene America is actively expanding capacity with new laboratories in Beaverton, Oregon and a forthcoming Australian facility, plus a UK Cambridge Omics Center metabolomics service. This signals continued growth and potential for regional contracts, service upsells, and scalable sequencing projects across North America, Australia, and Europe.

Multi-Omics Offerings Recent launches in untargeted metabolomics and DIA proteomics, along with expanded spatial transcriptomics capabilities, create opportunities to cross-sell integrated multi-omics pipelines to biotech firms, pharma, and academic customers seeking comprehensive data for translational research.

Strategic Partnerships Global collaborations and a strong UC Davis presence indicate a preference for alliance-driven projects. Target mid-to-large biotech and academic accounts seeking trusted genomic partners with multinational support, enabling joint grant work and multi-site studies.

Industrial Capabilities Leading sequencing capacity, diverse platforms (Illumina, PacBio, Nanopore) and a focus on high-throughput workflows position Novogene to win large-scale production sequencing, clinical genomics, and population-scale studies from customers needing reliable scale and data quality.

Brand & Thought Leadership Frequent industry events such as Multi-Omics Symposiums and participation in ASM Microbe demonstrate active thought leadership. Use these touchpoints to engage prospects through case studies, webinars, and demonstrations of integrated omics analyses to accelerate procurement cycles.